This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

BioProcess International US West
Mark Your Calendar for BPI US West 2024!
March 11-14, 2024Town and Country Resort, San Diego

Saurabh Sen
Associate Director, Cell Line Development, Genomic Medicine Unit CMC at Sanofi


Saurabh Sen is a research scientist with a with varied expertise in Gene Therapy, Antibody Therapeutics, and GPCRs. Saurabh is a SME on protein expression: both for transient platform as well as for stable cell line development.
In his current role as an Associate Director for Cell Line Development (CLD) at Sanofi, Saurabh is actively engaged in delivering top class stable cell lines both for AAV Gene Therapy as well as for Protein Biologics. Previously, at Boehringer Ingelheim (BI), he was leading Antibody Drug Discovery projects end-2-end - towards developing novel therapeutics for unmet medical needs.
Saurabh will be presenting on the PCL process for AAV production, the front runner AAV production platform at Sanofi. His talk will focus on how Automation can help build a robust cell line generation platform.

Agenda Sessions

  • An Automated and Data-Driven Future of Robust Producer Cell Line Development Platform for AAV Gene Therapy

  • Panel Discussion: How many cell lines should you have?